Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR
Abstract The molecular mechanism of Endoplasmic Reticulum-associated degradation (ERAD) of Cystic fibrosis transmembrane-conductance regulator (CFTR) is largely unknown. Particularly, it is unknown what ER luminal factor(s) are involved in ERAD. Herein, we used ProtoArray to identify an ER luminal c...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9ead2c7e3d246a98726846c361c73db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a9ead2c7e3d246a98726846c361c73db |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a9ead2c7e3d246a98726846c361c73db2021-12-02T15:08:21ZTargeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR10.1038/s41598-019-46161-42045-2322https://doaj.org/article/a9ead2c7e3d246a98726846c361c73db2019-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-46161-4https://doaj.org/toc/2045-2322Abstract The molecular mechanism of Endoplasmic Reticulum-associated degradation (ERAD) of Cystic fibrosis transmembrane-conductance regulator (CFTR) is largely unknown. Particularly, it is unknown what ER luminal factor(s) are involved in ERAD. Herein, we used ProtoArray to identify an ER luminal co-chaperone, DNAJB9, which can directly interact with CFTR. For both WT- and ΔF508 (deletion of phenylalanine at position 508, the most common CF-causing mutant)-CFTR, knockdown of DNAJB9 by siRNA increased their expression levels on the cell surface and, consequently, upregulated their function. Furthermore, genetic ablation of DNAJB9 in WT mice increased CFTR expression and enhanced CFTR-dependent fluid secretion in enteroids. Importantly, DNAJB9 deficiency upregulated enteroids’ fluid secretion in CF mice (homozygous for ΔF508), and silencing one allele of DNAJB9 is sufficient to rescue ΔF508-CFTR in vitro and in vivo, suggesting that DNAJB9 may be a rate-limiting factor in CFTR ERAD pathway. Our studies identified the first ER luminal co-chaperone involved in CFTR ERAD, and DNAJB9 could be a novel therapeutic target for CF.Yunjie HuangKavisha AroraKyu Shik MunFanmuyi YangChangSuk MoonSunitha YarlagaddaAnil JeggaTimothy WeaverAnjaparavanda P. NarenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-11 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Yunjie Huang Kavisha Arora Kyu Shik Mun Fanmuyi Yang ChangSuk Moon Sunitha Yarlagadda Anil Jegga Timothy Weaver Anjaparavanda P. Naren Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR |
description |
Abstract The molecular mechanism of Endoplasmic Reticulum-associated degradation (ERAD) of Cystic fibrosis transmembrane-conductance regulator (CFTR) is largely unknown. Particularly, it is unknown what ER luminal factor(s) are involved in ERAD. Herein, we used ProtoArray to identify an ER luminal co-chaperone, DNAJB9, which can directly interact with CFTR. For both WT- and ΔF508 (deletion of phenylalanine at position 508, the most common CF-causing mutant)-CFTR, knockdown of DNAJB9 by siRNA increased their expression levels on the cell surface and, consequently, upregulated their function. Furthermore, genetic ablation of DNAJB9 in WT mice increased CFTR expression and enhanced CFTR-dependent fluid secretion in enteroids. Importantly, DNAJB9 deficiency upregulated enteroids’ fluid secretion in CF mice (homozygous for ΔF508), and silencing one allele of DNAJB9 is sufficient to rescue ΔF508-CFTR in vitro and in vivo, suggesting that DNAJB9 may be a rate-limiting factor in CFTR ERAD pathway. Our studies identified the first ER luminal co-chaperone involved in CFTR ERAD, and DNAJB9 could be a novel therapeutic target for CF. |
format |
article |
author |
Yunjie Huang Kavisha Arora Kyu Shik Mun Fanmuyi Yang ChangSuk Moon Sunitha Yarlagadda Anil Jegga Timothy Weaver Anjaparavanda P. Naren |
author_facet |
Yunjie Huang Kavisha Arora Kyu Shik Mun Fanmuyi Yang ChangSuk Moon Sunitha Yarlagadda Anil Jegga Timothy Weaver Anjaparavanda P. Naren |
author_sort |
Yunjie Huang |
title |
Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR |
title_short |
Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR |
title_full |
Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR |
title_fullStr |
Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR |
title_full_unstemmed |
Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR |
title_sort |
targeting dnajb9, a novel er luminal co-chaperone, to rescue δf508-cftr |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/a9ead2c7e3d246a98726846c361c73db |
work_keys_str_mv |
AT yunjiehuang targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr AT kavishaarora targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr AT kyushikmun targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr AT fanmuyiyang targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr AT changsukmoon targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr AT sunithayarlagadda targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr AT aniljegga targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr AT timothyweaver targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr AT anjaparavandapnaren targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr |
_version_ |
1718388204823904256 |